Intra Cellular Therapies | ITCI - EPS Earnings Per Share


Intra Cellular Therapies reported $-0.16 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.



Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.48 Dec/2025
Prothena USD -0.46 0.22 Dec/2025
RedHill Biopharma USD -1.31 33.38 Jun/2024
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024